Addyi Health Fact Sheet

  What is Flibanserin (Addyi)? Flibanserin (brand name: Addyi) is the first drug approved by the U.S. Food and Drug Administration (FDA) to treat lack of sexual desire (Hypoactive Sexual Desire Disorder) in premenopausal women.  Although the drug is ineffective and potentially dangerous, the agency approved it in 2015 over the objections of the NWHN and … Continued

Snapshots

Breastfeeding has many benefits for both mother and child. Breast milk provides babies with nutritionally balanced food; promotes healthy growth; and lowers the risk of disease in newborns, young children, and mothers. Yet, a retrospective cohort study of 92,364 newborns (56,865 of whom were exclusively breastfed) reports that only 61.6% of mothers breastfeed, and the … Continued